Contribution of clinical pharmacokinetics to collect and detect medication errors in pediatrics;Place de la pharmacocinétique clinique dans la détection, la collecte et la déclaration des erreurs médicamenteuses en pédiatrie

Journal de Pharmacie Clinique

Volumn 24, Issue 1, 2005, Pages 31-39

  Savet, M ^a   Bertholle, V ^a   Vernardet, S ^b   Charpiat, B ^b   Constant, H ^a   Bleyzac, N ^a  

^a HÔPITAL DEBROUSSE   (France)

^b CROIX ROUSSE HOSPITAL   (France)

Author keywords

Clinical pharmacokinetics; Medication error; Pediatrics

Indexed keywords

ACICLOVIR; AMIKACIN; BUSULFAN; FOSCARNET; TOBRAMYCIN; VANCOMYCIN;

ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE; DRUG MONITORING; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; MEDICATION ERROR;

EID: 16344368345     PISSN: 02911981     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Koren G, Barzilay Z, Greenwald M. Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics. Pediatrics 1986; 77: 848-9.
2. Fortescue EB, Kaushal R, Landrigan CP, McKenna KJ, Clapp MD, Federico F, et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics 2003; 111: 722-8.
3. Vincer MJ, Murray JM, Yuill A, Allen AC, Evans JR, Stinson DA. Drugs errors and incidents in a neonatal intensive care unit. Am J Dis Child 1989; 143: 737-40.
4. http//www.adiph.org/aaqte, consulté en septembre 2003.
5. Maire P, Corvaisier S, Rougier F, Claude D, Ducher M, Barbaut X, ef al. Pharmacocinétique: pharmacodynamie clinique des antibiotiques. In: Manuel de bactériologie clinique. Paris: ESKA, 2003: 1-26.
6. Colombini N, Rochegude S, Bleyzac N, Sayhoun G, Souillet G, Aulagner G. Bilan de l'activité d'adaptation des pasologies de ciclasporine en transplantation pédiatrique de moelle osseuse. J Pharm Clin 1999; 18: 33-5.
7. Bleyzac N, Souillet G, Magron P, Janoly A, Martin P, Bertrand Y, et al. Improved clinical outcome of paediatric bone marrow recipients by using a test dose and bayesian pharmacokinetic monitoring af busulfan dosage regimens. Bone Marrow Transplant 2001; 28: 743-51.
8. Janoly-Duménil A, Bleyzac N, Richard I, Bourgeois J, Constant H, Putet G, et al. Intérêt de l'individualisation des posologies de vancomycine par une méthode bayésienne dans un service de réanimation néonatale. J Pharm Clin 2003; 22: 95-100.
9. Charpiat B, Bréant V, Pivot-Dumorest C, Maire P, Jelliffe R. Prédiction of future serum concentrations with Bayesian fitted pharmacokinetic models: result with data collected by nurses versus trained pharmacy residents. Ther Drug Monit 1994; 16: 166-73.
10. Labaune JM, Bleyzac N, Maire P, Jelliffe R, Putet G, Aulagner G, et al. A once-a-day individualized amikacin dosing nomogram for suspected sepsis in neonates less than 2-day old. Biol Neonate 2001; 80: 142-7.
11. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995; 274: 29-34.
12. Kaushal R. Using chart review to screen for medication errors and adverse drug events. Am J Health Syst Pharm 2002; 59: 2323-5.
13. Barker KN, Flynn EA, Pepper GA. Observation method of detecting medication errors. Am J Health Syst Pharm 2002; 59: 2314-6.
14. Shaw Phillips MA. Voluntary reporting of medication errors. Am J Health Syst Pharm 2002; 59: 2326-8.
15. Schiff G, Klass D, Peterson J, Shah G, Bates DW. Linking laboratory and pharmacy, opportunities for reducing errors and improving care. Arch Intern Med 2003; 163: 893-9.
16. Schneider PJ. Using technology to enhance measurement of drug-use safety. Am J Health Syst Pharm 2002; 59: 2330-2.
17. Belkacem-Kahlouli A, Audibert L, Massenavette B, Coudray S, Bleyzac N, Aulagner G. Utilisation d'une interaction médicamenteuse avec l'acide folinique dans le traitement d'une intoxication iatrogène à la fosphénytoïne. J Pharm Clin 2001; 20: 215-8.